Clinical Trials Sponsored by Taizhou Cancer Hospital

Total 10042 results

Henan Cancer Hospital

Not yet recruiting

Application of Douyin in Patients With Bone and Soft Tissue Malignant Tumors During Perichemotherapy

Chemotherapy | Malignant Tumor
Henan Cancer Hospital

Recruiting

Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors

Depression | Anxiety | Malignant Tumor

China
Henan Cancer Hospital

Recruiting

A Study of the Advanced Adenocarcinoma of Stomach and Gastroesophageal Junction With Camrelizumab+SOX Control Camrelizumab+SOX+ Trastuzumab

Advanced Gastric Adenocarcinoma

China
Zhejiang Cancer Hospital

Recruiting

Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer

Bladder Cancer

China
Hunan Cancer Hospital

Recruiting

UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases

Brain Metastases | Capecitabine | Metastatic HER2 Negative Breast Carcinoma | UDT1

China
Barretos Cancer Hospital

Recruiting

Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic Reconstruction (PROMART)

Breast Cancer

Brazil
Henan Cancer Hospital

Recruiting

Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma

Squamous Cell Carcinoma of the Skin

China
Fujian Cancer Hospital

Not yet recruiting

Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer

Immunotherapy
Hubei Cancer Hospital

Recruiting

Selected De-escalation Radiotherapy for Postoperative Head and Neck Squamous Cell Carcinoma (iCSDeR)

Surgery | Head and Neck Squamous Cell Carcinoma | Radiotherapy | Immunotherapy

China
Hunan Cancer Hospital

Recruiting

AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer

Ovarian Cancer

China
Henan Cancer Hospital

Recruiting

Camrelizumab Combined With Apatinib Mesylate

Solid Tumor

China
Henan Cancer Hospital

Recruiting

AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Henan Cancer Hospital

Recruiting

Pyrotinib Combined With Capecitabine in HER-2 Positive Advanced Breast Cancer and Brain Metastases (Post-PERMEATE)

Breast Cancer

China
Henan Cancer Hospital

Recruiting

Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure

HR Positive HER2 Negative Advanced Breast Cancer

China
Fujian Cancer Hospital

Recruiting

TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer

Colorectal Cancer | Immunotherapy

China
Henan Cancer Hospital

Recruiting

Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer

Breast Cancer

China
Fujian Cancer Hospital

Recruiting

Trifluridine/Tipiracil (TAS-102) With or Without Thalidomide for the Treatment of Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Zhejiang Cancer Hospital

Recruiting

A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Cervical Cancer

China
Zhejiang Cancer Hospital

Recruiting

Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Not yet recruiting

H101 Combined With Camrelizumab for Recurrent Cervical Cancer

Uterine Cervical Neoplasms | Oncolytic Virotherapy | Camrelizumab

China
Henan Cancer Hospital

Recruiting

Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System Lymphoma

Central Nervous System Lymphoma

China
Henan Cancer Hospital

Not yet recruiting

Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.

Recurrent Hepatocellular Cancer
Zhejiang Cancer Hospital

Recruiting

Radiotherapy Combined With Tislelizumab and Irinotecan in MSS/pMMR Recurrence and Metastatic Colorectal Cancer

Colorectal Cancer Metastatic | Microsatellite Stable | Mismatch Repair-proficient

China
Hubei Cancer Hospital

Recruiting

Impact of Baduanjin Qigong Exercise on Fatigue in Patients With NSCLC Undergoing Adjuvant Chemotherapy

Fatigue

China
Zhejiang Cancer Hospital

Recruiting

UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer

Rectal Cancer Stage III

China
Fujian Cancer Hospital

Not yet recruiting

the Role of ctDNA in Predicting the Recurrence Risk of Colorectal Cancer

Colorectal Cancer Stage II | Colorectal Cancer Stage III
Henan Cancer Hospital

Recruiting

PI3Kδ Inhibitor Parsaclisib Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-cell Lymphoma

Peripheral T-Cell Lymphoma

China
Henan Cancer Hospital

Recruiting

Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer

Breast Cancer

China
Zhejiang Cancer Hospital

Recruiting

A Study of Diarrhea and Intestinal Flora Changes Caused by Pyrotinib in Breast Cancer

Breast Cancer

China
Hubei Cancer Hospital

Recruiting

Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC

NSCLC

China
Zhejiang Cancer Hospital

Recruiting

Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer (PAILACC)

Cervical Cancer

China
Zhejiang Cancer Hospital

Not yet recruiting

A Phase II Study of Sintilimab Combined With Anlotinib in Treatment of ED-SCLC

Small Cell Lung Cancer Extensive Stage
Zhejiang Cancer Hospital

Not yet recruiting

HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis

Gastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and Surgery

China
Zhejiang Cancer Hospital

Not yet recruiting

A Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area Lymphoma

Chemotherapy Effect | Gray Zone Lymphoma | Relapse/Recurrence
Henan Cancer Hospital

Recruiting

A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)

NSCLC | Brain Metastases | Leptomeningeal Metastasis

China
Henan Cancer Hospital

Recruiting

Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer

Advanced Gastric Adenocarcinoma

China
Henan Cancer Hospital

Recruiting

Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

Diffuse Large B Cell Lymphoma | CD79A Gene Mutation | CD79B Gene Mutation

China
Zhejiang Cancer Hospital

Not yet recruiting

Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer

Breast Cancer
Zhejiang Cancer Hospital

Not yet recruiting

Neoadjuvant Short-course Radiotherapy Followed by the Combination of Immunotherapy and Chemotherapy in Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

China
Henan Cancer Hospital

Recruiting

Alotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer

SCLC, Extensive Stage

China
Henan Cancer Hospital

Recruiting

Comparing the Efficacy of Nab-PHP and TCbHP in Neoadjuvant Therapy for HER2 Positive Operable Breast Cancer

Breast Cancer,Her2 Positive

China
Henan Cancer Hospital

Recruiting

PD-1 Monoclonal Antibody Combined With FLOT Regimen for Neoadjuvant Therapy of Gastric Adenocarcinoma

Gastric and Esophagogastric Junction Adenocarcinoma

China
Henan Cancer Hospital

Not yet recruiting

Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC

Non-small Cell Lung Cancer Metastatic
Zhejiang Cancer Hospital

Not yet recruiting

Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung
Zhejiang Cancer Hospital

Recruiting

Single Cell Sequencing Analysis of Thymoma

Thymoma

China
Zhejiang Cancer Hospital

Not yet recruiting

Endostar Combined With Concurrent Radiochemotherapy for Treatment of Unresectable Stage III NSCLC (R-helper)

Unresectable Stage III NSCLC
Fujian Cancer Hospital

Not yet recruiting

POF Versus FOLFOX Plus IP Paclitaxel in AGC

Gastric Cancer
Henan Cancer Hospital

Recruiting

Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903) (HCHTOG1903)

Esophageal Squamous Cell Carcinoma

China
Henan Cancer Hospital

Recruiting

Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma

Classical Hodgkin Lymphoma

China
Henan Cancer Hospital

Recruiting

Study of CT and MR in the Lung Cancer

MRI | Genes | Response | Lung Cancer Squamous Cell | CT

China

3

Subscribe